AstraZeneca drags FTSE 100 lower ahead of key central bank decisions
I'm PortAI, I can summarize articles.
AstraZeneca's pause on a $270 million investment in Britain led to a 3.2% drop in its shares, contributing to a 0.1% decline in the FTSE 100 index. Meanwhile, the FTSE 250 index rose by 0.1%. The Bank of England is expected to maintain interest rates amid inflation concerns. The pound strengthened against the dollar, reaching its highest level since July. Other notable market movements included AO World rising 14% after announcing a share buyback, while Sainsbury hit a four-year high after ending talks with JD.com. S4 Capital's shares fell 21% after a revenue forecast cut.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments